- Home
- / Labcorp Drug Development
Labcorp Drug DevelopmentLabcorp Drug Development
Revenue
$5.8 B
FY, 2021
Labcorp Drug Development Summary
Company summary
- Overview
- Labcorp Drug Development (formerly known as Covance) is a contract research and drug development company. It offers laboratory testing services to the chemical and agrochemical industries. The company also provides toxicology, central laboratory, discovery, and Phase III clinical trial management services.
- Type
- Subsidiary
- Status
- Active
- Founded
- 1968
- HQ
- Princeton, NJ, US | view all locations
- Cybersecurity rating
Key people
William Hanlon, Chief Scientific Officer and President of Clinical Development & Commercialization Services, Clinical Therapy
Oren Cohen, Chief Medical Officer and President, Clinical Pharmacology Services
Jill McConnell, Chief Financial Officer
Operating MetricsView all
Trademarks (US)
24
9.1%
Nov, 2020
Patents
9
Nov, 2020
Services Provided
13
Nov, 2020
LocationsView all
79 locations detected
Princeton, NJ HQ
United States
206 Carnegie Center Dr
Ann Arbor, MI
United States
800 Technology Dr
Brentwood, TN
United States
201 Summit View Dr #200
Chantilly, VA
United States
3635 Concorde Pkwy #100
Dallas, TX
United States
1341 W Mockingbird Ln #200
Daytona Beach, FL
United States
1900 Mason Ave #140
Labcorp Drug Development Financials
Summary financials
- Revenue (Q2, 2022)
- $1.5B
- EBIT (Q2, 2022)
- $150.9M
